ResMed Inc (0KW4.L)

Healthcare | Medical Equipment Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 1,335,582,000 1,347,993,000 1,291,736,000 1,282,089,000
Cost of Revenue 514,762,000 527,923,000 525,328,000 530,814,000
Gross Profit 820,820,000 820,070,000 766,408,000 751,275,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 259,194,000 265,125,000 245,302,000 241,613,000
Operating Expenses 374,283,000 365,527,000 340,139,000 334,033,000
Operating Income 446,537,000 454,540,000 426,268,000 417,243,000
Interest Expense 8,793,000 0 0 4,788,000
Income Before Tax 446,793,000 458,053,000 417,693,000 418,322,000
Income Tax Expense 98,257,000 78,348,000 52,652,000 73,700,000
Net Income 348,536,000 379,705,000 365,041,000 344,622,000
Per Share
EPS 2.38 2.59 2.49 2.35
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Revenue 5,146,327,000 4,685,297,000 4,222,993,000
Cost of Revenue 2,091,357,000 2,029,994,000 1,867,331,000
Gross Profit 3,054,970,000 2,655,303,000 2,355,662,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 991,019,000 917,136,000 874,003,000
Operating Expenses 1,369,607,000 1,335,410,000 1,203,665,000
Operating Income 1,685,363,000 1,319,893,000 1,131,871,000
Interest Expense 12,609,000 45,708,000 47,379,000
Income Before Tax 1,677,566,000 1,264,798,000 1,101,664,000
Income Tax Expense 276,843,000 243,847,000 204,108,000
Net Income 1,400,723,000 1,020,951,000 897,556,000
Per Share
EPS 9.55 6.94 6.12
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 1,209,450,000 238,361,000 227,891,000
Short Term Investments 0 0 12,423,000
Net Receivables 939,492,000 837,275,000 704,909,000
Inventory 927,711,000 822,250,000 998,012,000
Total Current Assets 3,505,605,000 2,357,719,000 2,367,830,000
Property Plant Equipment 718,287,000 699,146,000 665,811,000
Goodwill and Intangibles 3,511,541,000 3,327,959,000 3,322,640,000
Total Assets 8,174,391,000 6,872,394,000 6,751,708,000
Liabilities
Account Payables 278,157,000 237,728,000 150,756,000
Short Term Debt 70,912,000 35,178,000 53,740,000
Total Current Liabilities 1,019,120,000 910,655,000 758,533,000
Long Term Debt 811,407,000 838,757,000 1,548,087,000
Total Liabilities 2,206,532,000 2,008,351,000 2,621,805,000
Shareholders Equity
Retained Earnings 6,081,490,000 4,991,647,000 4,253,016,000
Total Shareholders Equity 5,967,859,000 4,864,043,000 4,129,903,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 1,209,450,000 238,361,000 227,891,000
Short Term Investments 0 0 12,423,000
Net Receivables 939,492,000 837,275,000 704,909,000
Inventory 927,711,000 822,250,000 998,012,000
Total Current Assets 3,505,605,000 2,357,719,000 2,367,830,000
Property Plant Equipment 718,287,000 699,146,000 665,811,000
Goodwill and Intangibles 3,511,541,000 3,327,959,000 3,322,640,000
Total Assets 8,174,391,000 6,872,394,000 6,751,708,000
Liabilities
Account Payables 278,157,000 237,728,000 150,756,000
Short Term Debt 70,912,000 35,178,000 53,740,000
Total Current Liabilities 1,019,120,000 910,655,000 758,533,000
Long Term Debt 811,407,000 838,757,000 1,548,087,000
Total Liabilities 2,206,532,000 2,008,351,000 2,621,805,000
Shareholders Equity
Retained Earnings 6,081,490,000 4,991,647,000 4,253,016,000
Total Shareholders Equity 5,967,859,000 4,864,043,000 4,129,903,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income 1,400,723,000 1,020,951,000 897,556,000
Depreciation & Amortization 235,811,000 216,209,000 197,562,000
Stock Based Compensation 91,661,000 80,184,000 71,142,000
Change in Working Capital 16,738,000 44,784,000 -462,127,000
Operating Cash Flow 1,751,588,000 1,401,260,000 693,299,000
Investing Activities
Capital Expenditure -89,865,000 -114,856,000 -134,000,000
Investments -89,865,000 -99,460,000 -134,000,000
Investing Cash Flow -200,045,000 -269,784,000 -1,159,845,000
Financing Activities
Debt Repayment -40,000,000 -730,000,000 665,000,000
Common Stock Issued/Repurchased -225,586,000 -96,917,000 49,142,000
Dividends Paid -310,880,000 -282,320,000 -258,276,000
Financing Cash Flow -606,253,000 -1,119,287,000 422,874,000
Summary
Free Cash Flow 1,661,723,000 1,286,404,000 559,299,000
Net Change in Cash 971,089,000 10,470,000 -45,819,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income 1,400,723,000 1,020,951,000 897,556,000
Depreciation & Amortization 235,811,000 216,209,000 197,562,000
Stock Based Compensation 91,661,000 80,184,000 71,142,000
Change in Working Capital 16,738,000 44,784,000 -462,127,000
Operating Cash Flow 1,751,588,000 1,401,260,000 693,299,000
Investing Activities
Capital Expenditure -89,865,000 -114,856,000 -134,000,000
Investments -89,865,000 -99,460,000 -134,000,000
Investing Cash Flow -200,045,000 -269,784,000 -1,159,845,000
Financing Activities
Debt Repayment -40,000,000 -730,000,000 665,000,000
Common Stock Issued/Repurchased -225,586,000 -96,917,000 49,142,000
Dividends Paid -310,880,000 -282,320,000 -258,276,000
Financing Cash Flow -606,253,000 -1,119,287,000 422,874,000
Summary
Free Cash Flow 1,661,723,000 1,286,404,000 559,299,000
Net Change in Cash 971,089,000 10,470,000 -45,819,000